{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:28:43Z","timestamp":1783535323317,"version":"3.55.0"},"reference-count":38,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"vor","delay-in-days":44,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To study cardiometabolic risk-factor trajectories (in terms of levels and changes over time) preceding diabetic polyneuropathy (DPN) 13 years after a screen-detected diagnosis of type 2 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We clinically diagnosed DPN in a nested case-control study of 452 people in the Danish arm of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION). By linear regression models, we estimated preceding risk-factor trajectories during 13 years. Risk of DPN was estimated by multivariate logistic regression models of each individual\u2019s risk-factor trajectory intercept and slope adjusting for sex, age, diabetes duration, height, and trial randomization group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Higher baseline levels of HbA1c (odds ratio [OR] 1.76 [95% CI 1.37; 2.27] and OR 1.68 [95% CI 1.33; 2.12] per 1% and 10 mmol\/mol, respectively) and steeper increases in HbA1c over time (OR 1.66 [95% CI 1.21; 2.28] and OR 1.59 [95% CI 1.19; 2.12] per 1% and 10 mmol\/mol increase during 10 years, respectively) were associated with DPN. Higher baseline levels of weight, waist circumference, and BMI were associated with DPN (OR 1.20 [95% CI 1.10; 1.31] per 5 kg, OR 1.27 [95% CI 1.13; 1.43] per 5 cm, and OR 1.24 [95% CI 1.12; 1.38] per 2 kg\/m2, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Both higher levels and slopes of HbA1c trajectories were associated with DPN after 13 years. Our findings indicate that the rate of HbA1c increase affects the development of DPN over and above the effect of the HbA1c level. Furthermore, this study supports obesity as a risk factor for DPN.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc18-0392","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T13:55:14Z","timestamp":1531144514000},"page":"1955-1962","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":35,"title":["Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark"],"prefix":"10.2337","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5183-3502","authenticated-orcid":false,"given":"Signe T.","family":"Andersen","sequence":"first","affiliation":[{"name":"Section for General Medical Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Witte","sequence":"additional","affiliation":[{"name":"Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark"},{"name":"Danish Diabetes Academy, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4724-7276","authenticated-orcid":false,"given":"Lasse","family":"Bjerg","sequence":"additional","affiliation":[{"name":"Section for General Medical Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"},{"name":"Danish Diabetes Academy, Odense, Denmark"},{"name":"Clinical Epidemiology, Steno Diabetes Center Copenhagen, Gentofte, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Henrik","family":"Bruun","sequence":"additional","affiliation":[{"name":"Section for General Medical Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8356-5565","authenticated-orcid":false,"given":"Marit E.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology, Steno Diabetes Center Copenhagen, Gentofte, Denmark"},{"name":"National Institute of Public Health, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna B.","family":"Finnerup","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Lauritzen","sequence":"additional","affiliation":[{"name":"Section for General Medical Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels S.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Tankisi","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurophysiology, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Charles","sequence":"additional","affiliation":[{"name":"Section for General Medical Practice, Department of Public Health, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"2022031303354665200_B1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ana.410380607","article-title":"Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial","volume":"38","author":"DCCT Research Group","year":"1995","journal-title":"Ann Neurol"},{"key":"2022031303354665200_B2","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031303354665200_B3","first-page":"CD007543","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","volume":"6","author":"Callaghan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2022031303354665200_B4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/WCO.0b013e328357a797","article-title":"Diabetic neuropathy: one disease or two","volume":"25","author":"Callaghan","year":"2012","journal-title":"Curr Opin Neurol"},{"key":"2022031303354665200_B5","doi-asserted-by":"crossref","first-page":"d4169","DOI":"10.1136\/bmj.d4169","article-title":"Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials","volume":"343","author":"Boussageon","year":"2011","journal-title":"BMJ"},{"key":"2022031303354665200_B6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N Engl J Med"},{"key":"2022031303354665200_B7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-53480-4.00001-1","article-title":"Epidemiology of polyneuropathy in diabetes and prediabetes","volume":"126","author":"Ziegler","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"2022031303354665200_B8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/dmrr.2239","article-title":"Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy","volume":"28","author":"Tesfaye","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031303354665200_B9","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1136\/jnnp-2016-314171","article-title":"Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study","volume":"87","author":"Hanewinckel","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2022031303354665200_B10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031303354665200_B11","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2337\/dc13-1544","article-title":"Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study","volume":"37","author":"Sandb\u00e6k","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031303354665200_B12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1900\/RDS.2015.12.48","article-title":"Risk factors and comorbidities in diabetic neuropathy: an update 2015","volume":"12","author":"Papanas","year":"2015","journal-title":"Rev Diabet Stud"},{"key":"2022031303354665200_B13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc16-0081","article-title":"Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status","volume":"39","author":"Callaghan","year":"2016","journal-title":"Diabetes Care"},{"key":"2022031303354665200_B14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-017-4253-z","article-title":"Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study","volume":"60","author":"Look AHEAD Research Group","year":"2017","journal-title":"Diabetologia"},{"key":"2022031303354665200_B15","first-page":"245","article-title":"[Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author\u2019s transl)]","volume":"3","author":"Pirart","year":"1977","journal-title":"Diabete Metab"},{"key":"2022031303354665200_B16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2337\/diab.38.11.1456","article-title":"Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study","volume":"38","author":"Maser","year":"1989","journal-title":"Diabetes"},{"key":"2022031303354665200_B17","first-page":"1068","article-title":"Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark","volume-title":"Diabetes Care","author":"Andersen","year":"2018"},{"key":"2022031303354665200_B18","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031303354665200_B19","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2337\/dc08-0500","article-title":"Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy","volume":"29","author":"Perkins","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031303354665200_B20","doi-asserted-by":"crossref","first-page":"e86515","DOI":"10.1371\/journal.pone.0086515","article-title":"Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"2022031303354665200_B21","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/sj.ijo.0801420","article-title":"The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening","volume":"24","author":"Lauritzen","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2022031303354665200_B22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(11)60698-3","article-title":"Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial","volume":"378","author":"Griffin","year":"2011","journal-title":"Lancet"},{"key":"2022031303354665200_B23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2022031303354665200_B24","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2337\/diacare.17.11.1281","article-title":"A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy","volume":"17","author":"Feldman","year":"1994","journal-title":"Diabetes Care"},{"key":"2022031303354665200_B25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1464-5491.2011.03500.x","article-title":"Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy","volume":"29","author":"Spallone","year":"2012","journal-title":"Diabet Med"},{"key":"2022031303354665200_B26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/mus.22074","article-title":"Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy","volume":"44","author":"Dyck","year":"2011","journal-title":"Muscle Nerve"},{"key":"2022031303354665200_B27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031303354665200_B28","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.hjr.0000368191.86614.5a","article-title":"The global burden of diabetes and its complications: an emerging pandemic","volume":"17","author":"van Dieren","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"2022031303354665200_B29","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2337\/dc14-2459","article-title":"Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe)","volume":"38","author":"Herman","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031303354665200_B30","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/practneurol-2013-000758","article-title":"The clinical approach to small fibre neuropathy and painful channelopathy","volume":"14","author":"Themistocleous","year":"2014","journal-title":"Pract Neurol"},{"key":"2022031303354665200_B31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1302\/0301-620X.78B2.0780276","article-title":"The significance of an absent ankle reflex","volume":"78","author":"Bowditch","year":"1996","journal-title":"J Bone Joint Surg Br"},{"key":"2022031303354665200_B32","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00125-008-1156-z","article-title":"The Danish National Diabetes Register: trends in incidence, prevalence and mortality","volume":"51","author":"Carstensen","year":"2008","journal-title":"Diabetologia"},{"key":"2022031303354665200_B33","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jamaneurol.2016.3745","article-title":"Association between metabolic syndrome components and polyneuropathy in an obese population","volume":"73","author":"Callaghan","year":"2016","journal-title":"JAMA Neurol"},{"key":"2022031303354665200_B34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/dc07-1796","article-title":"Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA\/KORA Augsburg Surveys S2 and S3","volume":"31","author":"Ziegler","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031303354665200_B35","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1592\/phco.24.13.1194.38084","article-title":"Statin-associated peripheral neuropathy: review of the literature","volume":"24","author":"Chong","year":"2004","journal-title":"Pharmacotherapy"},{"key":"2022031303354665200_B36","first-page":"401","article-title":"Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled phase IIa study","volume":"7","author":"Hern\u00e1ndez-Ojeda","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2022031303354665200_B37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00125-007-0919-2","article-title":"Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study","volume":"51","author":"Davis","year":"2008","journal-title":"Diabetologia"},{"key":"2022031303354665200_B38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MED.0000000000000320","article-title":"Mediators of diabetic neuropathy: is hyperglycemia the only culprit","volume":"24","author":"Grisold","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/41\/9\/1955\/552552\/dc180392.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/41\/9\/1955\/552552\/dc180392.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T08:11:37Z","timestamp":1647159097000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/41\/9\/1955\/40724\/Risk-Factor-Trajectories-Preceding-Diabetic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,7,9]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc18-0392","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,9]]}}}